Quantum-Si’s Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025

About this update from Quantum-si Incorporated

BRANFORD, Conn., February 18, 2025 --( BUSINESS WIRE )-- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company ™ , and several distinguished researchers will be presenting new research and applications at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting February 23-26 th . Quantum-Si, the pioneer in Next-Generation Protein Sequencing (NGPS™) will feature groundbreaking research through one company-led poster and two customer-led posters highlighting the transformative capabilities of NGPS in multi-omics research and drug discovery. Scientific Posters Highlighting NGPS Innovation Beyond the genome: Advancing our understanding of the proteome with Next-Generation Protein Sequencing ™ Integrating long-read RNAseq and Next-Generation Protein Sequencing™ to explore proteoform variability Identifying Protein Binding Partners at the Bench Using Quantum-Si About Quantum-Si Incorporated Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum ® line of instruments enables Next-Gen Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X . View source version on businesswire.com: https://www.businesswire.com/news/home/20250218012265/en/ Contacts Investor Contact Jeff Keyes Chief Financial Officer [email protected] Media Contact Katherine Atkinson SVP, Commercial Marketing [email protected]

View stock analysis, news, and events for Quantum-si Incorporated